CEACAM5 and cancer: Among the CEACAM proteins, CEACAM5 is a well-known biomarker and indicator of recurrence in cancer patients and an established candidate for targeted experimental anticancer immunotherapies, e.g., using antibody–drug conjugates [19] or CAR T-cells [20].